Direct ex vivo analysis of dendritic cells in patients with hepatocellular carcinoma
Open Access
- 1 January 2006
- journal article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 12 (20), 3275-3282
- https://doi.org/10.3748/wjg.v12.i20.3275
Abstract
AIM: To analyze the phenotype and function of dendritic cells (DC) from patients with hepatocellular carcinoma (HCC) in order to understand their role in this disease. METHODS: Myeloid dendritic cells were enumerated in peripheral blood of HCC patients. CD80, CD83, CD86 and HLA-DR expression on naïve and stimulated myeloid dendritic cells from peripheral blood were analyzed. Myeloid dendritic cells were isolated from peripheral blood and their function was tested. Phagocytosis was analyzed using FITC-dextran beads, peptide specific stimulation, the capacity to stimulate allogeneic T cells and secretion of cytokines upon poly dI:dC was tested. RESULTS: Myeloid dendritic cells were reduced in patients with HCC. No differences in CD80, CD83, CD86 and HLA-DR expression were found on naïve and stimulated myeloid dendritic cells from HCC patients and healthy controls. Normal phagocytosis or stimulation of peptide specific T cells was observed in contrast to an impaired allo-stimulatory capacity and a reduced IL-12 secretion. CONCLUSION: Impaired IL-12 production of mDCs in patients could lead to an impaired stimulatory capacity of naïve T cells suggesting that IL-12 directed therapies may enhance tumor specific immune responses in HCC patients.Keywords
This publication has 45 references indexed in Scilit:
- Therapie des hepatozellulären KarzinomsZeitschrift für Gastroenterologie, 2006
- Thalidomide in the treatment of patients with hepatocellular carcinomaCancer, 2005
- Mechanisms and functional significance of tumour-induced dendritic-cell defectsNature Reviews Immunology, 2004
- Toll-like receptor control of the adaptive immune responsesNature Immunology, 2004
- Functional impairment of myeloid and plasmacytoid dendritic cells of patients with chronic hepatitis BHepatology, 2004
- Spontaneous Tumor-Specific Humoral and Cellular Immune Responses to NY-ESO-1 in Hepatocellular CarcinomaClinical Cancer Research, 2004
- Presence of functional dendritic cells in patients chronically infected with hepatitis C virusBlood, 2004
- Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL ConferenceJournal of Hepatology, 2001
- Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cellsNature Medicine, 1996
- Transection of the oesophagus for bleeding oesophageal varicesBritish Journal of Surgery, 1973